Catalog No.
Product Name
Application
Product Information
Citations
-
Drug Impurity
Solifenacin impurity 10 is a drug impurity associated with Solifenacin. This compound is relevant for analytical chemistry and quality control studies in pharmaceutical research. It serves as a reference standard in the identification and quantification of impurities during Solifenacin synthesis, ensuring compliance with regulatory standards in drug development. -
Perphenazine Impurity
4-[3-(10H-Phenothiazin-10-yl)propyl]-1-piperazineethanol is identified as a Perphenazine impurity. It shares structural similarities with Perphenazine, a typical antipsychotic agent, and serves as a valuable reference compound for analytical studies. This impurity can be utilized in research applications focusing on pharmaceutical development, quality control, and stability testing of Perphenazine-containing formulations. -
Lacosamide Impurity
(Rac)-Desmethyl lacosamide is a known impurity of lacosamide and serves as a significant intermediate in the synthesis of this anticonvulsant drug. This compound can be used in chemical research to study the properties and effects of lacosamide and its derivatives. Its characterization is essential for ensuring the purity and efficacy of lacosamide formulations in therapeutic applications. -
Drug Impurity
Clopidogrel impurity 8 is a metabolite impurity associated with the antiplatelet agent Clopidogrel. This compound is significant for quality control and analytical studies in pharmaceutical research, particularly in assessing the purity of Clopidogrel formulations. It serves as a valuable reference standard for the identification and quantification of impurities in drug development and stability testing. -
Drug Impurity
Fusidic acid impurity 1, also known as 16-Epidesacetylfusidic acid, is a chemical impurity associated with fusidic acid. This compound serves as a significant marker in the quality control of fusidic acid production, aiding in the purification and identification of active pharmaceutical ingredients. Research applications include its use in stability studies and the analysis of drug formulation quality in pharmaceutical development. -
Drug Impurity
Betamethasone acetate impurity 1, also known as Betamethasone 11,21-diacetate, is characterized as a drug impurity of Betamethasone acetate. Its presence can impact the efficacy and safety profiles of pharmaceutical formulations. This compound is essential for quality control and analytical research, providing insight into the purity and stability of corticosteroid products. -
Drug Impurity
Tenofovir impurity 1, also known as Tenofovir impurity E, is a significant impurity of the antiretroviral drug Tenofovir. It is essential for quality control and analytical studies during the synthesis of Tenofovir. Researchers can utilize this compound to assess the purity and stability of Tenofovir formulations in pharmaceutical development and regulatory compliance. -
Drug Impurity
Salmeterol impurity 7, also known as Salmeterol impurity H, is a defined impurity of the bronchodilator Salmeterol. This compound is utilized primarily in drug quality control and analytical studies to ensure the purity and efficacy of pharmaceutical formulations. Its presence in Salmeterol formulations may affect therapeutic outcomes, making it essential for rigorous quality assurance processes in pharmaceutical research and development. -
Drug Impurity
Naproxen impurity 6, also known as Naproxen Nitrile impurity, is a chemical impurity associated with the nonsteroidal anti-inflammatory drug (NSAID) Naproxen. This compound is primarily utilized in the analysis of drug formulations and quality control to ensure the purity and safety of pharmaceutical products. Its understanding is crucial for regulatory compliance and for studying the degradation pathways of Naproxen during storage and processing. -
Drug Impurity
Atorvastatin impurity 7 calcium is a known impurity associated with Atorvastatin calcium, a widely used statin for cholesterol management. As a research reagent, it serves as a reference standard in the characterization and analysis of Atorvastatin formulations. Its identification is crucial for ensuring the quality and safety of pharmaceutical products containing Atorvastatin. -
Drug Impurity
Flurbiprofen impurity 2 is a known impurity of the nonsteroidal anti-inflammatory drug (NSAID) Flurbiprofen. This compound is relevant for quality control and regulatory compliance in pharmaceutical development, as it highlights potential variations in drug purity. It can be utilized in research applications focused on the analysis of drug formulations and the assessment of the safety and efficacy profiles of NSAIDs. -
Drug Impurity
Telmisartan impurity 7, also known as Telmisartan bromo ethyl ester, functions primarily as a drug impurity associated with the pharmaceutical compound Telmisartan. This compound is important for quality control and analytical studies, enabling researchers to assess the purity and stability of Telmisartan formulations. Its analysis can aid in ensuring compliance with regulatory standards in drug development and manufacturing processes. -
Drug Impurity
Cinacalcet impurity 1 is a chemical impurity associated with Cinacalcet, a calcimimetic agent targeting the calcium-sensing receptor. This impurity is primarily used in pharmaceutical research to evaluate the purity and formulation of Cinacalcet, ensuring compliance with quality control protocols in drug development. It serves as an important reference standard for analytical purposes. -
Drug Impurity
N-(4-(N-(Cyclohexylcarbamoyl)sulfamoyl)phenethyl)-6-methylpyrazine-2-carboxamide, known as Glipizide Impurity, serves as a chemical impurity in the synthesis of the antidiabetic agent Glipizide. This compound can be utilized to investigate the stability, purity, and quality of pharmaceutical formulations containing Glipizide. Researchers studying drug metabolism and impurity profiles in pharmaceutical contexts may find this reagent valuable for their analytical and quality control applications. -
Drug Impurity
Rivaroxaban impurity 3 is a known impurity associated with the anticoagulant Rivaroxaban. This compound is utilized primarily in analytical chemistry for the quality control and characterization of Rivaroxaban formulations. Its identification and quantification are essential for ensuring the purity and safety of pharmaceutical products containing Rivaroxaban. -
Drug Impurity
Azilsartan impurity 10 is a chemical impurity related to the antihypertensive agent Azilsartan. This compound serves as a reference standard for analytical methods used in the characterization and quantification of drug impurities. Its use is essential in the development and quality control of pharmaceutical formulations to ensure compliance with regulatory standards. -
Drug Impurity
Escitalopram impurity 3 is a known impurity of the selective serotonin reuptake inhibitor Escitalopram, primarily involved in the pharmacological modulation of serotonin levels in the brain. Its characterization is essential for ensuring the quality and safety of pharmaceutical formulations containing Escitalopram. This reagent serves as a reference standard in studies focusing on impurity profiling and the evaluation of product stability in drug development and quality control processes. -
Drug Impurity
Sildenafil impurity 16 is a chemical impurity related to the phosphodiesterase type 5 (PDE5) inhibitor Sildenafil. As an impurity, it may be of interest in analytical chemistry for purity assessment and characterization of Sildenafil formulations. This compound is crucial for quality control and compliance in pharmaceutical development, particularly in the synthesis and evaluation of PDE5 inhibitors. -
Drug Impurity
Acyclovir impurity 5 is a characterized impurity of Acyclovir, an antiviral medication targeting viral DNA polymerase. This compound is essential for the evaluation of drug purity and safety, making it useful in the analysis of formulation quality and compliance with regulatory standards in pharmaceutical development. It serves as a crucial reference material for method validation and quality control in laboratories engaged in antiviral research and drug formulation studies. -
Betahistine Impurity
N,N-Dimethyl-2-pyridineethylamine is an identified impurity of Betahistine, a medication primarily used for the treatment of vestibular disorders. This compound serves as a useful reference standard in the analysis of Betahistine's purity and quality in pharmaceutical research. Its presence may influence the pharmacokinetics and safety profile of Betahistine, making it significant for analytical and quality control laboratories engaged in drug development and testing. -
Drug Impurity
Dexmedetomidine impurity 5 is identified as N-Ethylmedetomidine, a structural impurity of Dexmedetomidine. This compound plays a critical role in quality control and analytical studies to ensure the purity and safety of dexmedetomidine formulations. Researchers may utilize this impurity to investigate its effects in pharmacokinetic and toxicological assessments, thereby contributing to a better understanding of drug metabolism and efficacy. -
Drug Impurity
Trimetazidine impurity 5 is a drug impurity associated with trimetazidine, a medication primarily used for the treatment of angina pectoris. This compound serves as an important reference standard for the analysis and characterization of trimetazidine formulations in pharmaceutical research. It is essential for ensuring the quality and purity of drug substances, facilitating the development and validation of analytical methods in drug testing and quality control. -
Drug Impurity
Trazodone impurity 10, also known as Trazodone N-Oxide, is a known impurity found in Trazodone synthesis. Its presence can influence the pharmacological profile and safety evaluation of Trazodone formulations. This compound serves as a valuable reference for analytical method development, quality control, and stability studies within pharmaceutical research focused on Trazodone-related compounds. -
Drug Impurity
Beclometasone dipropionate impurity 3 is a known impurity associated with Beclometasone dipropionate, a corticosteroid medication. This compound can be utilized in the assessment of drug purity and stability, contributing to the quality control of pharmaceutical formulations. Researchers may employ this impurity in analytical testing protocols to ensure compliance with regulatory standards in drug development and manufacturing processes. -
Drug Impurity
Roxithromycin impurity 4, also known as Roxithromycin impurity D, is a chemical byproduct associated with the antibiotic Roxithromycin. This impurity can be utilized in research focused on the synthesis and characterization of drug formulations, particularly in assessing the quality and stability of Roxithromycin. Understanding impurities like Roxithromycin impurity 4 is crucial for regulatory compliance and ensuring the safety and efficacy of pharmaceutical products. -
Drug Impurity
Atorvastatin impurity 2 calcium is a known impurity of the cholesterol-lowering agent Atorvastatin calcium. This compound is utilized primarily in the quality control and analytical assessment of Atorvastatin formulations to ensure purity and compliance with pharmacopoeial standards. The characterization of this impurity is essential for researchers engaged in pharmaceutical development and regulatory submissions. -
Drug Impurity
Linagliptin impurity 1, also known as Bromo butene linagliptin impurity VII, is a specific drug impurity associated with Linagliptin. This compound may serve as a reference standard in analytical studies focused on the purity assessment and quality control of Linagliptin formulations. Researchers can utilize this impurity to evaluate the presence and concentration of impurities during the development and manufacturing processes of related pharmaceutical products. -
Drug Impurity
Atenolol impurity 6 is a byproduct of Atenolol synthesis. As a drug impurity, it serves as an important reference standard for quality control and analytical testing in pharmaceutical development. This compound is utilized to assess the purity of Atenolol and to study its potential effects during formulation and stability testing. -
Drug Impurity
Citalopram impurity 4 oxalate, also known as 3-Oxocitalopram oxalate, is a recognized impurity associated with the synthetic pathway of Citalopram oxalate. This compound serves as a crucial standard in pharmaceutical quality control, enabling the identification and quantification of impurities in Citalopram formulations. Its presence is relevant in research focused on drug metabolism and the assessment of drug purity and safety in pharmacological studies. -
Aceclofenac Impurity
Aceclofenac methyl ester is a key impurity of Aceclofenac, an orally active nonsteroidal anti-inflammatory drug (NSAID) recognized for its analgesic and anti-inflammatory effects. This compound is significant for research applications involving the characterization and validation of Aceclofenac, allowing for a comprehensive analysis of its pharmacological profile and potential impact in various inflammatory conditions. -
Drug Impurity
Clopidogrel impurity 10 is an impurity associated with the antiplatelet drug Clopidogrel, which primarily targets the P2Y12 receptor on platelets. This impurity is critical for evaluating the purity and quality of Clopidogrel formulations in pharmaceutical research. It serves as a reference standard in drug development and quality control processes, ensuring the reliability of therapeutic applications. -
Drug Impurity
Beclometasone dipropionate impurity 9 is a known impurity associated with the corticosteroid Beclometasone dipropionate. It serves as a critical reference standard for quality control and analysis in pharmaceutical development, ensuring the purity and safety of corticosteroid formulations. Its characterization is essential for regulatory compliance and in assessing the stability and efficacy of related drug products. -
Drug Impurity
Atorvastatin impurity 9 is a chemical impurity associated with the statin drug Atorvastatin. It is primarily studied for its role in drug quality control and formulation integrity. This impurity is relevant for researchers investigating the safety and efficacy profiles of Atorvastatin, contributing to the understanding of its pharmacological properties and potential impacts on patient treatment outcomes. -
Drug Impurity
Chlorthalidone impurity 2 is an identified impurity associated with the antihypertensive agent Chlorthalidone. This compound is primarily utilized in analytical chemistry to assess the purity and quality of Chlorthalidone in pharmaceutical formulations. It serves as a crucial reference standard for researchers investigating the metabolite profile and potential side effects of Chlorthalidone-based therapies. -
Drug Impurity
Tamsulosin impurity 3 is a recognized impurity associated with Tamsulosin, a selective alpha-1 adrenergic antagonist. This compound serves as an important reference standard in the pharmaceutical industry for quality control and stability testing of Tamsulosin formulations. Its characterization aids in ensuring the purity and safety of therapeutic preparations utilizing Tamsulosin. -
Drug Impurity
Fenirofibrate impurity 2 is a minor impurity associated with the lipid-modulating drug Fenirofibrate. This compound is relevant for drug quality control and stability testing in pharmaceutical research. Its identification and quantification play a crucial role in ensuring the purity and safety of Fenirofibrate formulations, aiding in the development of effective therapeutic strategies for dyslipidemia. -
Drug Impurity
Trazodone impurity 1, also known as Trazodone 1,4-Di-N-oxide, is a known impurity associated with the pharmaceutical compound Trazodone. This reagent is utilized primarily in the assessment of drug purity and stability during analytical testing. Its presence and quantification are critical for ensuring the quality of Trazodone formulations in pharmaceutical research and development. -
Drug Impurity
Lidocaine impurity 20 is a known impurity associated with the local anesthetic agent Lidocaine. This compound serves as a critical reference standard for quality control during the synthesis and analysis of Lidocaine formulations. Its identification and characterization are essential for ensuring the purity and efficacy of Lidocaine-containing products in pharmaceutical research and development. -
Drug Impurity
Trazodone impurity 2, also known as Dechloro trazodone, is a known impurity associated with the pharmaceutical compound Trazodone. This compound may be utilized in the assessment of drug purity and stability during formulation development and quality control processes. Its analysis can provide valuable insights into the chemical profile of Trazodone formulations, aiding in the understanding of potential impacts on efficacy and safety. -
Drug Impurity
Ethinylestradiol impurity 2, also known as 16-Oxo ethynyl estradiol, serves as a notable impurity in the synthesis of Ethinylestradiol. Its characterization is essential for quality control and regulatory compliance in pharmaceutical development. This compound can be utilized in various analytical applications, including stability studies and impurity profiling, providing critical insights into the purity and safety of hormone-related therapeutic formulations. -
Drug Impurity
Clobazam impurity 4 is a chemical impurity associated with the pharmaceutical agent Clobazam, a benzodiazepine used primarily for its anxiolytic properties. This impurity may arise during the synthesis of Clobazam and is relevant for analytical chemistry and quality control in drug development. Research applications include the assessment of drug purity, stability studies, and pharmacokinetic investigations. -
Drug Impurity
Trazodone impurity 4 hydrochloride is a chemical impurity associated with Trazodone hydrochloride. It serves as an important reference standard in the evaluation of drug purity and is relevant for quality control processes in pharmaceutical research. The presence of this impurity can impact the pharmacological profile and safety of formulations containing Trazodone, making it essential for analytical methods in drug development and regulatory compliance. -
Drug Impurity
Candesartan impurity 11 is a chemical impurity associated with Candesartan, an angiotensin II receptor antagonist. This impurity is significant for quality control and analytical studies in pharmaceutical research, particularly for characterizing Candesartan formulations. Its presence can affect the safety and efficacy profiles of drug products, making it essential for thorough impurity profiling in drug development processes. -
Drug Impurity
Sitagliptin impurity 19 is a chemical impurity associated with the antidiabetic agent Sitagliptin. It is utilized primarily in pharmaceutical development and quality control to assess the purity and stability of Sitagliptin formulations. This reagent is essential for ensuring compliance with regulatory standards and for conducting detailed investigations into the drug's chemical profile. -
Drug Impurity
Rivaroxaban impurity 33 is a drug impurity associated with Rivaroxaban, an anticoagulant that inhibits Factor Xa. This impurity is vital for quality control and analytical studies in pharmaceutical development and can be used in characterizing the purity of Rivaroxaban formulations. Its presence is significant for researchers involved in drug safety assessments and regulatory compliance in pharmaceutical research. -
Drug Impurity
Betamethasone dipropionate impurity 2 is a known impurity of the corticosteroid, Betamethasone dipropionate, which serves as a glucocorticoid receptor agonist. This compound may be relevant for research involving the purification and characterization of drug formulations, as well as studies on the stability and efficacy of corticosteroid therapies. Understanding this impurity is essential for ensuring quality control in the production of pharmacologically active compounds. -
Drug Impurity
Dabigatran impurity 2 is a quality control reference standard identified as an impurity of Dabigatran. This compound is utilized primarily in analytical chemistry for the detection and quantification of impurities in Dabigatran formulations. It serves as a critical reagent for research focused on the pharmacokinetics and safety profiles of anticoagulant medications. -
Drug Impurity
Donepezil impurity 21 is a known impurity of the cognitive-enhancing agent Donepezil, which primarily targets acetylcholinesterase to enhance cholinergic neurotransmission. This compound is essential for the analysis of Donepezil formulations, particularly in the context of pharmaceutical quality control and regulatory compliance. Its characterization aids in understanding the stability and purity of Donepezil, supporting ongoing research in neurodegenerative disease therapies. -
Drug Impurity
Lincomycin impurity 4 is a known impurity associated with lincomycin, an antibiotic that targets the bacterial ribosome to inhibit protein synthesis. This compound serves as an important reference standard for quality control and analytical assessment in pharmaceutical development and research. It is valuable for studying the stability, efficacy, and safety profiles of lincomycin formulations. -
Drug Impurity
Oxcarbazepine impurity 3, also known as 11-Keto Oxcarbazepine, is a recognized impurity of the anticonvulsant drug Oxcarbazepine. This compound is relevant in the pharmaceutical research and quality control of antiepileptic medications. Its presence and characterization are essential for ensuring the purity and efficacy of drug formulations.
